Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
76.00
-0.20 (-0.26%)
Aug 15, 2025, 2:31 PM CST

Foresee Pharmaceuticals Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
867.251,3671,010689.51871.441,145
Upgrade
Short-Term Investments
75-150-100125
Upgrade
Trading Asset Securities
----297.47351.68
Upgrade
Cash & Short-Term Investments
942.251,3671,160689.511,2691,622
Upgrade
Cash Growth
-3.14%17.90%68.19%-45.66%-21.76%226.86%
Upgrade
Accounts Receivable
63.5132.3365.9116.27--
Upgrade
Other Receivables
10.9426.5522.1810.135.7313.97
Upgrade
Receivables
74.4658.8888.0926.45.7313.97
Upgrade
Inventory
139.12183.87126.8176.4124.8834.11
Upgrade
Prepaid Expenses
99.27132.4823.5622.753.99.71
Upgrade
Other Current Assets
-75192.5--6.62
Upgrade
Total Current Assets
1,2551,8181,591915.061,3031,686
Upgrade
Property, Plant & Equipment
190.07217.62135.01142.3991.19110.8
Upgrade
Other Intangible Assets
114.41117.79126.81140.96155.14209.44
Upgrade
Long-Term Deferred Tax Assets
1.171.311.231.221.11.14
Upgrade
Other Long-Term Assets
5.094.97.76104.3990.5892.06
Upgrade
Total Assets
1,5662,1591,8611,3041,6412,100
Upgrade
Accounts Payable
51.1964.4212.1322.85--
Upgrade
Accrued Expenses
91.5485.57120.7178.4761.6845.8
Upgrade
Short-Term Debt
150150200--30.07
Upgrade
Current Portion of Long-Term Debt
-5---20.79
Upgrade
Current Portion of Leases
5.3612.4115.1415.5210.29.38
Upgrade
Current Income Taxes Payable
10.728.8210.424.95--
Upgrade
Current Unearned Revenue
47.550.03105.481.010.781.52
Upgrade
Other Current Liabilities
73.3916.976.966.381.7914.03
Upgrade
Total Current Liabilities
429.7393.21470.83129.1774.45121.59
Upgrade
Long-Term Debt
90.4292.92---63.24
Upgrade
Long-Term Leases
--13.1225.86.456.68
Upgrade
Long-Term Unearned Revenue
72.6272.62131.67237.15239.1777.67
Upgrade
Long-Term Deferred Tax Liabilities
1.261.411.321.321.191.22
Upgrade
Total Liabilities
593.99560.15616.93393.43321.26270.4
Upgrade
Common Stock
1,5491,5481,3581,1821,1791,169
Upgrade
Additional Paid-In Capital
5,9025,9064,6173,4243,3723,319
Upgrade
Retained Earnings
-6,433-5,811-4,730-3,693-3,221-2,651
Upgrade
Comprehensive Income & Other
-45.71-44.56-1.49-1.54-10.21-8.06
Upgrade
Shareholders' Equity
971.841,5991,245910.581,3201,829
Upgrade
Total Liabilities & Equity
1,5662,1591,8611,3041,6412,100
Upgrade
Total Debt
245.77260.33228.2641.3216.65130.15
Upgrade
Net Cash (Debt)
696.481,107931.42648.191,2521,492
Upgrade
Net Cash Growth
-7.51%18.85%43.70%-48.24%-16.05%208.45%
Upgrade
Net Cash Per Share
4.768.067.325.4910.6714.71
Upgrade
Filing Date Shares Outstanding
153.93154.79135.82118.17117.94116.94
Upgrade
Total Common Shares Outstanding
153.93154.79135.82118.17117.94116.94
Upgrade
Working Capital
825.41,4241,120785.891,2291,565
Upgrade
Book Value Per Share
6.3110.339.167.7111.1915.64
Upgrade
Tangible Book Value
857.431,4811,118769.621,1651,620
Upgrade
Tangible Book Value Per Share
5.579.578.236.519.8813.85
Upgrade
Land
-123.07----
Upgrade
Buildings
-9.96----
Upgrade
Machinery
-226.59209.45171.58136.94144.58
Upgrade
Construction In Progress
--4.920.394.41.31
Upgrade
Leasehold Improvements
-30.4430.447.717.717.71
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.